MA11.09 SAKK 16/18: Neoadjuvant Chemotherapy, Durvalumab and Immune-Modulatory RT in Stage III(N2) NSCLC. Surgical Interim Analysis
| Autor: | Dorn, P., Holer, L., Lardinois, D., Dutly, A., Karenovics, W., Habicht, J., Lutz, J.A., Gelpke, H., Opitz, I., Haefliger, S., König, D., Früh, M., Addeo, A., Vonder Mühll-Schill, C., Bettini, A., Scheibe, B., Savic Prince, S., Guckenberger, M., Finazzi, T., Rothschild, S.I., Mauti, L.A. |
|---|---|
| Zdroj: | In Journal of Thoracic Oncology November 2023 18(11) Supplement:S139-S140 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|